As Eli Lilly's Mounjaro prescriptions skyrocket, analyst predicts $50B in yearly tirzepatide sales
No matter how you look at it, the obesity drug market is shaping up to be vast. And the spotlight right now is on Eli …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
